Two Sigma Advisers
AEGR

Two Sigma Advisers’s Aegerion Pharmaceuticals AEGR Stock Holding History

Two Sigma Advisers’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-15,267
Closed -$45K – 2536
2016
Q3 		$45K Sell
15,267
-22,500
-60% -$39K ﹤0.01% 2178
2016
Q2 		$56K Buy
+37,767
New +$86.4K ﹤0.01% 2008

Two Sigma Advisers's AEGR Position: Q4 2016 in Review

Two Sigma Advisers sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 15,267 shares — an estimated $45K sold.

Two Sigma Advisers first reported a position in AEGR in Q2 2016 and held it in 2 quarters. The position peaked at $56K in Q2 2016. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

  • Two Sigma Advisers reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Two Sigma Advisers sold 15,267 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $45K.
  • Two Sigma Advisers first reported a position in Aegerion Pharmaceuticals in Q2 2016 and held it in 2 quarters.
  • Two Sigma Advisers's Aegerion Pharmaceuticals position peaked at $56K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Two Sigma Advisers's 13F filing for Q4 2016, filed 14 Feb 2017.